Skip to main content
Cynthia (Foss) Bowman, MD, Pathology, East Orange, NJ

Cynthia L (Foss) Bowman MD

Anatomic Pathology, Clinical Pathology


Chief, Pathology and Laboratory Medicine Services, VA New Jersey Health Care System, East Orange, New Jersey

Join to View Full Profile
  • 385 Tremont Ave.Lab113East Orange, NJ 07018

  • Phone+1 973-676-1000

Dr. Bowman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1975 - 1980
  • University of California (San Francisco) School of Medicine
    University of California (San Francisco) School of MedicineInternship, Transitional Year, 1974 - 1975
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1974

Certifications & Licensure

  • ME State Medical License
    ME State Medical License 1987 - 2026
  • MA State Medical License
    MA State Medical License 2002 - 2025
  • NY State Medical License
    NY State Medical License 2004 - 2025
  • Anatomic Pathology & Clinical Pathology
    American Board of Pathology Anatomic Pathology & Clinical Pathology

Press Mentions

  • Severe COVID-19 Pneumonia Is Associated with Increased Plasma Immunoglobulin G Agonist Autoantibodies Targeting the 5-Hydroxytryptamine 2A Receptor
    Severe COVID-19 Pneumonia Is Associated with Increased Plasma Immunoglobulin G Agonist Autoantibodies Targeting the 5-Hydroxytryptamine 2A ReceptorFebruary 2nd, 2021
  • Severe COVID-19 Pneumonia Is Associated with Increased Plasma Immunoglobulin G Agonist Autoantibodies Targeting the 5-Hydroxytryptamine 2A Receptor
    Severe COVID-19 Pneumonia Is Associated with Increased Plasma Immunoglobulin G Agonist Autoantibodies Targeting the 5-Hydroxytryptamine 2A ReceptorMarch 13th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: